PANoptosis-Relevant Subgroups Predicts Prognosis and Characterizes the Tumour Microenvironment in Ovarian Cancer
Yuwei Chen,Zhibo Deng,Jian Chen,Jie Lin,Jianping Zou,Sang Li,Yang Sun
DOI: https://doi.org/10.2147/jir.s483977
IF: 4.5
2024-11-28
Journal of Inflammation Research
Abstract:Yuwei Chen, 1, &ast Zhibo Deng, 2, &ast Jian Chen, 1 Jie Lin, 1 Jianping Zou, 1 Sang Li, 1 Yang Sun 1 1 Department of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian Province, People's Republic of China; 2 Department of Orthopedics, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, Fujian Province, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yang Sun, Department of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, 350014, People's Republic of China, Email Background: Ovarian cancer (OC) poses a significant health burden with high mortality rates among female reproductive malignancies. Variability in treatment responses underscores the need for reliable prognostic markers to refine risk stratification. PANoptosis, a novel form of programmed cell death, plays pivotal roles in cancer pathogenesis and therapy. However, its prognostic relevance in OC remains unclear. Methods: Utilizing data from The Cancer Genome Atlas (TCGA), we analyzed transcriptomic and clinical signatures of OC patients. Through consensus clustering, we delineated molecular subtypes associated with PANoptosis-related genes (PRGs). We constructed and validated prognostic models using LASSO and Cox regression analyses, corroborated with GEO dataset validation. CIBERSORT assessed immune cell infiltration by risk score, and a predictive algorithm evaluated chemotherapy responses. Additionally, we investigated the biological role of the key gene CXCL13 in OC and its response to immunotherapy. Results: Based on 19 PRGs, we identified two OC subtypes (PAN-Cluster1, PAN-Cluster2). Machine learning-derived risk scores using PAN-Cluster differentially expressed genes emerged as an independent prognostic indicator. Distinct risk groups exhibited varying clinical outcomes, immune profiles, drug sensitivities, and mutational landscapes. Notably, we confirmed CXCL13 as a model key gene and explored its role in OC regulation. In OC cells, suppression of CXCL13 expression enhances cell proliferation and migration, while patients with high CXCL13 expression show an improved response to immunotherapy. Conclusion: We initially identified the molecular subtypes associated with PRGs and established a prognostic model related to PRGs to predict survival and drug response in OC patients. Although further validation is required, these findings offer valuable insights into the development of personalized treatment strategies for OC patients. Keywords: PANoptosis, ovarian cancer, tumor microenvironment, drug sensitivity, prognosis Ovarian cancer (OC) is the most malignant tumor among gynecological tumors, posing a serious threat to women's health. 1 In recent years, advancements in surgical techniques, chemotherapy, molecular targeted therapy, and immunotherapy drugs have led to a significant increase in the survival rate of OC patients. 2 Due to the lack of typical clinical manifestations of early-stage OC, and the lack of effective screening methods and therapeutic targets at this stage, patients with significant symptoms may often be in the advanced stage. 3 Therefore, there is an urgent need to find the factors associated with OC prognosis and their molecular mechanisms, which are essential to provide effective treatment and improve patient outcomes. Programmed cell death (PCD) is an evolutionarily conserved biological process that plays a central role in maintaining the body's physiological balance. 4 Among all known types of PCD, pyrodeath, apoptosis, and necrosis are typical ways of controlling the initiation, transduction, and execution of cell death through complex molecular mechanisms. 5 PANoptosis is a PCD pattern that combines the features of apoptosis, pyrodeath and necrotic apoptosis and cannot be replaced alone. 6,7 Due to the complex mechanism of PANoptosis, it has been widely studied in recent years. Studies have found that the disorder of PANoptosis is related to various human diseases, including autoinflammatory diseases, cancer, infectivity and metabolic disorders. Research has confirmed that PANoptosis can induce cell death in different cancer cell lines. Cell death provides host defense and maintains homeostasis, indicating that PANoptosis plays an important role in tumor progression. 8,9 The phenotypic heterogeneity of tumor samples can be comprehensively evaluated by multi-omics analysis, which plays an important role in the screening and mechanism -Abstract Truncated-
immunology